Tag: Pomalidomide

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Pomalidomide

FDA Requests Belantamab Mafodotin for R/R Multiple Myeloma Be Pulled From US Market

Added to Collection on: 2022-11-22 23:02:40

Tags for this article:

Drugs
Orphan drugs
Medicine
Clinical medicine
Daratumumab
Bortezomib
Pomalidomide
Multiple myeloma
Proteasome inhibitor
Dexamethasone
Isatuximab
Carfilzomib

Click the tags to see associated articles and topics

View Article Details
Janssen Presents New Data for Talquetamab, a GPRC5DxCD3 Bispecific Antibody ...

Added to Collection on: 2022-12-10 23:16:48

Tags for this article:

Medicine
Drugs
Clinical medicine
Orphan drugs
Cancer treatments
Monoclonal antibodies
Immune system
Immunosuppressants
Daratumumab
Multiple myeloma
Pomalidomide
Chimeric antigen receptor T cell
Johnson & Johnson
Janssen Pharmaceutica NV
Janssen Pharmaceutical Companies
Johnson & Johnson's

Click the tags to see associated articles and topics

View Article Details
Relapsing/Refractory Multiple Myeloma Market to Observe Stupendous Growth by 2032 ...

Added to Collection on: 2024-01-25 22:02:47

Tags for this article:

Orphan drugs
Elotuzumab
Multiple myeloma
Celgene
AbbVie
Pomalidomide
Lenalidomide
Amgen
Carfilzomib
Bortezomib
Daratumumab
Selinexor

Click the tags to see associated articles and topics

View Article Details
Isa-EloPD Shows Promise in Multiple Myeloma Management - Targeted Oncology

Added to Collection on: 2024-02-28 18:07:51

Tags for this article:

Orphan drugs
Elotuzumab
Isatuximab
Multiple myeloma
Cereblon E3 ligase modulator
Lenalidomide
Pomalidomide
CD38
Selinexor
Daratumumab
Dexamethasone

Click the tags to see associated articles and topics

View Article Details
U.S. FDA Approves Bristol Myers Squibb and 2seventy bio'sAbecma for Triple-Class ...

Added to Collection on: 2024-04-06 13:28:46

Tags for this article:

Orphan drugs
Idecabtagene vicleucel
Multiple myeloma
Elotuzumab
Carfilzomib
Pomalidomide
Lenalidomide
CAR T cell
Daratumumab
Ixazomib
Bristol-Myers Squibb
2SEVENTY BIO, INC.
United States
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
ADC Improvements Mean More Targets, New Questions About Sequencing

Added to Collection on: 2024-06-10 15:20:39

Tags for this article:

Orphan drugs
Cancer treatments
Antineoplastic drugs
Antibody-drug conjugate
Triple-negative breast cancer
Multiple myeloma
Chemotherapy regimen
Pomalidomide
Seagen
HER2
Sacituzumab govitecan
Chemotherapy
Sarah Cannon Research Institute
Trastuzumab
Astellas

Click the tags to see associated articles and topics

View Article Details
EHA 2024: Monoclonal antibodies continue to dominate multiple myeloma treatments

Added to Collection on: 2024-06-21 22:47:30

Tags for this article:

Orphan drugs
Isatuximab
Multiple myeloma
Pomalidomide
Daratumumab
Lenalidomide
Dexamethasone
Bortezomib
Selinexor
Elotuzumab

Click the tags to see associated articles and topics

View Article Details
Carvykti Demonstrates Clinically Meaningful Improvement in Patients with Relapsed or ...

Added to Collection on: 2024-07-03 15:46:15

Tags for this article:

Orphan drugs
Multiple myeloma
Daratumumab
Elotuzumab
Carfilzomib
Lenalidomide
Ciltacabtagene autoleucel
Pomalidomide
Cereblon E3 ligase modulator
Bortezomib
CAR T cell
B-cell maturation antigen

Click the tags to see associated articles and topics

View Article Details
Blenrep shows overall survival benefit in head-to-head DREAMM-7 phase III trial for ...

Added to Collection on: 2024-11-15 10:22:01

Tags for this article:

Orphan drugs
B-cell maturation antigen
Belantamab mafodotin
Multiple myeloma
Daratumumab
Antibody-drug conjugate
Pomalidomide
Seagen
Bortezomib
Monomethyl auristatin F
Isatuximab
Daratumumab/hyaluronidase
gsk plc

Click the tags to see associated articles and topics

View Article Details
FDA Accepts GSK's Biologics License Application of Blenrep for Relapsed or Refractory ...

Added to Collection on: 2024-12-02 19:42:08

Tags for this article:

Orphan drugs
Multiple myeloma
Pomalidomide
Bortezomib
Belantamab mafodotin
Dexamethasone
Monomethyl auristatin F
Biologics license application
Daratumumab/hyaluronidase
Elotuzumab

Click the tags to see associated articles and topics

View Article Details